Bortezomib For Injection
Found 6 free book(s)Sr. Drug Generic Name of the Medicine Unit Size MRP ...
janaushadhi.gov.in82 809 Bortezomib Injection 3.5 mg Vial Vial 3188. 00 Anticancer/Oncology 83 819 Capecitabine Tab I.P 500mg 10's 420.0 0 Anticancer/Oncology 84 851 Dacarbazine Injection 200mg VIAL Vial 188.0 0 Anticancer/Oncology 85 853 Daunorubicin HCl Injection 20mg vial Vial 204.0 0 Anticancer/Oncology 86 916 Imatinib mesylate Tablets IP 400mg 10's
DARATUMUMAB WITH BORTEZOMIB AND …
nssg.oxford-haematology.org.ukBortezomib** 1.3 mg/m2 TWICE a week given as SC bolus Days 1,4,8 and 11 Dexamethasone 20mg PO once daily on the day of and day after bortezomib injection Days 2**, 4, 5, 8, 9, 11 and 12 *On day 1, dexamethasone is given as pre-med 1 …
DOSE BANDING TABLES - HSE.ie
www.hse.iebortezomib subcutaneous injection (version 1) The dose bands used in this table are constructed based on a 2.5mg/ml concentration of bortezomib Dose rounding has been applied to the lower end of this table in order to facilitate the nearest measurable volume
Prescribing Information | VELCADE® (bortezomib)
www.velcade.comVELCADE® (bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 -----INDICATIONS AND USAGE----- VELCADE is a proteasome inhibitor indicated for: treatment of adult patients with multiple myeloma (1.1) treatment of adult patients with mantle cell lymphoma (1.2)
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euBortezomib should be administered via subcutaneous injection (1.3 mg/m2 body surface area) twice weekly on days 1, 4, 8 and 11 of each 21-day. For additional information on the dose, schedule and dose adjustments of medicinal products administered with
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euVELCADE 1mg powder for solution for injection is administered via intravenous injection in combination with oral melphalan and oral prednisone as shown in Table2. A 6-week period is considered a treatment cycle. In Cycles1-4, VELCADE is administered twice weekly on days1, 4, 8, 11, 22, 25, 29 and 32.